Vishal Gulati

Vishal Gulati has a wealth of work experience in the healthcare industry. Vishal began their career in 2012 as a Healthtech VC for a Venture Capitalist. In 2013, they joined Molten Ventures as a Healthtech VC, where they were responsible for healthcare deals and leveraging the power of data and/or connectivity to make significant improvement in patient experience and outcome. In 2017, they became an Advisor/Investor for ZOE, and in 2016 they took on the role of Non Executive Director for Fluidic Analytics. In 2018, they became an Advisor/Investor for Turbine.AI, Kheiron Medical, Endomag, and Closed Loop Medicine. In 2020, they began working for Cancer Research UK (CRUK) as the Chairman of Seed Fund Investment Committee and became a Member of the Board of Advisors for Reuben College, University of Oxford.

Vishal Gulati has a long educational history. Vishal obtained a Clinical Research Fellow, Postgraduate Medicine from Imperial College London in 1995. Vishal was also awarded a Rhodes Scholarship in 1995 and a UNESCO Fellowship from the University of Oxford in 1994. Additionally, they were certified as a 100 Most Influential Health Tech Leaders 2016 by Hot Topics.